Scarica l'app Stockscreener
1.15
0.88%
0.01
Pre-mercato:
1.16
0.01
+0.87%
Precedente Chiudi:
$1.14
Aprire:
$1.12
Volume 24 ore:
2.81M
Relative Volume:
0.64
Capitalizzazione di mercato:
$165.61M
Reddito:
-
Utile/perdita netta:
$-119.76M
Rapporto P/E:
-0.8519
EPS:
-1.35
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
+7.48%
1M Prestazione:
+173.42%
6M Prestazione:
+211.65%
1 anno Prestazione:
-87.06%
Intervallo 1D:
$1.03
$1.15
Intervallo di 1 settimana:
$0.9004
$1.165
Portata 52W:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Nome
Applied Therapeutics Inc
Settore
Industria
Telefono
212-220-9226
Indirizzo
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Confronta APLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
1.15 | 164.17M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Downgrade | UBS | Buy → Neutral |
| 2024-11-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Iniziato | William Blair | Outperform |
| 2024-03-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-22 | Iniziato | Leerink Partners | Outperform |
| 2022-01-04 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Downgrade | Goldman | Neutral → Sell |
| 2021-06-25 | Ripresa | Goldman | Neutral |
| 2020-10-08 | Iniziato | Truist | Buy |
| 2020-04-22 | Iniziato | Goldman | Buy |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2019-06-10 | Iniziato | Citigroup | Buy |
| 2019-06-10 | Iniziato | Cowen | Outperform |
| 2019-06-10 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Applied Therapeutics Inc Borsa (APLT) Ultime notizie
Will Applied Therapeutics Inc. stock reach all time highs in 2025Earnings Summary Report & Capital Efficient Trading Techniques - newser.com
Applied Therapeutics' (APLT) "Sell (E+)" Rating Reiterated at Weiss Ratings - MarketBeat
Published on: 2025-10-14 04:19:23 - newser.com
How strong is Applied Therapeutics Inc. stock revenue growthMarket Risk Summary & Technical Pattern Based Signals - newser.com
Published on: 2025-10-14 01:57:01 - newser.com
Applied Therapeutics Inc. stock trendline breakdownJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
What the charts say about Applied Therapeutics Inc. todayWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
Is Applied Therapeutics Inc. stock reversal real or fakeJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
How Applied Therapeutics Inc. stock compares to industry benchmarksWeekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Applied Therapeutics Inc. (NASDAQ:APLT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Applied Therapeutics Inc Stock Analysis and ForecastStock Price Targets & Optimize Entry & Exit With Smart Signals - earlytimes.in
Can Applied Therapeutics Inc. hit a new high this monthWeekly Stock Report & High Yield Stock Recommendations - newser.com
How to use Fibonacci retracement on Applied Therapeutics Inc.2025 Top Decliners & Verified Stock Trade Ideas - newser.com
Why retail investors favor Applied Therapeutics Inc. stockWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Earnings visualization tools for Applied Therapeutics Inc.CPI Data & Accurate Entry and Exit Point Alerts - newser.com
Will Applied Therapeutics Inc. stock benefit from automationJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
What drives Applied Therapeutics Inc stock priceAI-Driven Market Analysis & Maximum Profit Growth - earlytimes.in
Is Applied Therapeutics Inc a good long term investmentIPO Market Watch & Budget Friendly Growth Tips - earlytimes.in
4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga
After losing 87% in the past year, Applied Therapeutics, Inc. (NASDAQ:APLT) institutional owners must be relieved by the recent gain - simplywall.st
Applied Therapeutics Settled With Investors Over Govorestat FDA Rejection – How to Claim Your Payout - TradingView
Why Applied Therapeutics Inc. is moving todayEarnings Summary Report & Community Supported Trade Ideas - newser.com
Will Applied Therapeutics Inc. continue its uptrendTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Detecting price anomalies in Applied Therapeutics Inc. with AIEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Is Applied Therapeutics Inc. stock near bottom after declineQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Institutional investors may adopt severe steps after Applied Therapeutics, Inc.'s (NASDAQ:APLT) latest 19% drop adds to a year losses - Yahoo Finance
Custom strategy builders for tracking Applied Therapeutics Inc.Quarterly Risk Review & Expert Curated Trade Setup Alerts - newser.com
What analysts say about Applied Therapeutics Inc stockMarket Sentiment Shifts & Optimize Entry & Exit With Smart Signals - earlytimes.in
Are Analysts Raising Price Targets for Can Fin Homes Limited AgainValue Stock Picks & Demo Trading Rooms Open Daily - earlytimes.in
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
How Applied Therapeutics Inc. stock trades during market volatilityGold Moves & Weekly Top Gainers Alerts - newser.com
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2025-09-30 | Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | NDAQ:APLT | Press Release - Stockhouse
Applied Therapeutics Inc Azioni (APLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Applied Therapeutics Inc Azioni (APLT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
5.15%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):